Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

MINIMS PREDNISOLONE Single-use eye drops (2017)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

Minims Prednisolone Sodium Phosphate.

Qualitative and quantitative composition

Clear, colourless, sterile eye drops containing Prednisolone Sodium Phosphate Ph. Eur. 0.5% w/v. For the full list of excipients, see section 6.1.

Pharmaceutical form

Sterile single-use eye drop.

Therapeutic indications

Non-infected inflammatory conditions of the eye.

Posology and method of administration

Posology Adults and the elderly One or two drops applied topically to the eye as required. Paediatric population At the discretion of the physician.

Contraindications

Use is contraindicated in viral, fungal, tuberculous and other bacterial infections. Prolonged application to the eye of preparations containing corticosteroids has caused increased intraocular pressure ...

Special warnings and precautions for use

Care should be taken to ensure that the eye is not infected before Minims Prednisolone is used. Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during ...

Interaction with other medicinal products and other forms of interaction

Corticosteroids are known to increase the effects of barbiturates, sedative hypnotics and tricyclic antidepressants. They will, however, decrease the effects of anticholinesterases, antiviral eye preparations ...

Pregnancy and lactation

Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development and although the relevance of this finding to human beings has not been established, the use ...

Effects on ability to drive and use machines

Not relevant.

Undesirable effects

Eye disorders Not known: vision, blurred (see also section 4.4) Prolonged treatment with corticosteroids in high dosage is occasionally associated with cataract. The systemic effects of steroids are possible ...

Overdose

As Minims are single dose units, overdose is unlikely to occur.

Pharmacodynamic properties

Pharmacotherapeutic group: Corticosteroids, plain ATC code: S01BA04 Mechanism of action The actions of corticosteroids are mediated by the binding of the corticosteroid molecules to receptor molecules ...

Pharmacokinetic properties

The oral availability, distribution and excretion of prednisolone is well documented. A figure of 82 ± 13% has been quoted as the oral availability and 1.4 ± 0.3ml/min/kg as the clearance rate. A half ...

Preclinical safety data

The use of prednisolone in ophthalmology is well-established. Little specific toxicology work has been reported, however, the breadth of clinical experience confirms its suitability as a topical ophthalmic ...

List of excipients

Disodium edetate Sodium dihydrogen phosphate Sodium chloride Sodium hydroxide for pH adjustment Purified water

Incompatibilities

Not applicable.

Shelf life

15 months.

Special precautions for storage

Store below 25°C. Do not freeze. Protect from light.

Nature and contents of container

A sealed conical shaped polypropylene container fitted with a twist and pull off cap. Each Minims unit is overwrapped in an individual polypropylene/paper pouch. Each container holds approximately 0.5ml ...

Special precautions for disposal and other handling

Each Minims unit should be discarded after a single use. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Marketing authorization holder

Bausch & Lomb UK Limited, Bausch & Lomb House, 106 London Road, Kingston-Upon-Thames, Surrey, UK, KT2 6TN

Marketing authorization number(s)

PL 03468/0079

Date of first authorization / renewal of the authorization

Date of first authorisation: 11<sup>th</sup> March 1981

Date of revision of the text

08 May 2017

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:

Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.